When Should a Dentist Sell to a DSO? A Decision Checklist

A single-location general practice doing $1.4 million in collections can get a DSO offer with a $1.3 million headline number on it, and still be the worse of the two choices on the table. Not because the buyer lowballed, and not because the multiple was wrong, but because roughly two thirds of that check is money the owner was going to earn anyway over the next four years, handed over early and taxed at once.

Here's the claim an informed owner can argue with: for a single-location general practice under about $1.5 million in collections, a DSO sale is not a wealth event. It's a liquidity event that converts your own future paychecks into a lump sum at a discount, and the only thing it reliably buys you is a date on the calendar when you stop being the owner. If you don't need that date, you probably shouldn't sell. We'll defend that for the rest of this piece, including the specific conditions under which we'd tell you the opposite.

13% of Dentists Are DSO-Affiliated. That Is Not an Argument.

The consolidation numbers are real and they're moving. ADA Health Policy Institute data puts DSO affiliation at 13% of U.S. dentists in 2022, up from 10.4% in 2019 and 8.8% in 2017. Among dentists five or fewer years out of school it's 27%, against 18% for those six to ten years out.

Owners read that trend as a countdown clock. It isn't one. The affiliation rate is being driven mostly by where new graduates take their first job, not by owners selling out at the top of a market. A 27% affiliation rate among recent grads tells you something important about your associate hiring pipeline and almost nothing about whether your practice should be sold this year. The trend affects your labor market first and your exit market second.

What it does change is who your buyer pool is. A practice that once had three plausible local buyers may now have one local buyer and two regional platforms. That shifts the negotiation, but it doesn't change the arithmetic of what a deal is worth to you.

The $1.4M Practice That Sells for $1.32M and Still Loses

Take a six-operatory general practice collecting $1.4 million. The owner produces $900,000 of that and the associate produces the rest. Profit before owner compensation runs 35%, so $490,000 a year lands in the owner's pocket in some combination of salary, distributions and perks.

A DSO doesn't buy that $490,000. It buys adjusted EBITDA, which means it first replaces the owner's clinical production with a market-rate associate cost. At 30% of $900,000, that's $270,000 of normalized dentist compensation. Adjusted EBITDA is therefore $220,000.

Published DSO-buyer multiples run roughly 5x to 7x for a single location, 7x to 9x at $1 million to $3 million of profit, 9x to 11x at $3 million to $5 million, and 10x to 12x for $5 million-plus platforms, with 12x about the ceiling in general dentistry. Call it 6x here, which is a fair, non-insulting number for a clean single site. Enterprise value: $1.32 million.

That is a real headline. Now hold it against what the owner actually receives. Typical structures hold back 20% to 30% as rollover equity or an earnout, so cash at close around 75% of the number is $990,000, before tax.

And the day after close, the owner's income from the chair drops from $490,000 to the $270,000 associate rate. That's $220,000 a year of lost cash flow. Sellers typically commit to three to five years of continued clinical employment post-close, so over a four-year commitment the owner forgoes $880,000 of earnings they would have collected by doing the exact same clinical work as an owner.

Set the $1.32 million enterprise value against $880,000 of forgone owner earnings across the commitment period and the net economic gain is about $440,000, before tax, before transaction costs, and before you account for the fact that the seller who holds for four more years still owns a sellable asset at the end of it.

Our view: at 6x on $220,000 of adjusted EBITDA, with a four-year clinical commitment attached, we wouldn't take that deal. The money is real but it's mostly your own money, pulled forward, with a non-compete stapled to it.

What Most Owners Get Wrong: Treating the Multiple as the Price

The specific mistake, and it's made most often by owners in their late forties and early fifties with one strong location and no partner, is negotiating hard on the multiple and barely reading the employment agreement.

Owners will spend six weeks pushing a buyer from 5.5x to 6.25x on $220,000 of EBITDA. That fight is worth $165,000 of enterprise value, of which maybe $124,000 arrives in cash. Meanwhile the post-close compensation formula, which is the single largest line item in the whole transaction, gets accepted as standard paper. Drop the production percentage from 30% to 27% and the owner loses $27,000 a year, or $108,000 over four years, which erases most of what the multiple fight won.

The second version of the same error is treating rollover equity as cash with a delay. It isn't. It's a minority position in a private company, with no dividend, no control, and a payout that depends on a future recapitalization at a multiple nobody can promise you. The upside case is genuine: platform equity bought in at 6x and sold at 10x inside a larger entity is the one structural way a small seller captures the multiple arbitrage that makes consolidation work. But that's an investment thesis, not consideration. Price it like venture exposure, not like an escrow.

Burnout Is a Real Reason to Sell and a Terrible Reason to Negotiate

The honest reason most owners pick up the phone isn't valuation. It's that they're done. More than 90% of dentists in a 2023 ADA survey reported career-related stress, and more than 40% said that at least monthly in the prior six months they felt defeated, wanted to quit dentistry, or didn't want to go to work. That is the actual market driver behind a lot of small-practice deal flow.

We're not going to tell you to tough it out. If the administrative load is what's grinding you down, handing off credentialing, payroll, hiring and insurance negotiation has real value that doesn't show up anywhere in a multiple. But understand what burnout does to a negotiation: it makes the exit date the only term you care about, and a buyer who senses that will give you the date and take everything else.

The fix is unglamorous. Hire the office manager or associate first, get your weeks down to something survivable, and then negotiate from a position where walking away is a live option. An owner who can credibly keep operating for three more years gets a materially different deal than one who can't face another quarter.

Why the Median Listed Practice Isn't DSO Bait

Scale is the whole game on the buy side, and most practices don't have it. According to the Practice Market Index, our dataset of 1,036 dental practices currently listed for sale by brokers, the median listing collects $996,000, with the middle half between $660,000 and $1.5 million (n=849). For general practices specifically the median is $957,000 (n=729). Median operatory count is 5, middle half 4 to 7 (n=849). These describe the asking side of the market, not practices generally, and they say nothing about what any of them sell for.

What they do say is that the typical practice on the market sits well below the profit thresholds where multiples step up. A sub-$1 million practice rarely generates the adjusted EBITDA that gets a platform's attention at a serious price, which is why the owners of those practices are competing for private buyers and associates-turned-owners, not for DSO term sheets. If you want the 7x to 9x band, the path runs through a second location or a materially more productive single one, not through a better broker.

One number worth checking against your own: median collections per operatory among listings is $200,000, middle half $147,250 to $266,563 (n=726). If you're running six ops at $233,000 each, you're using your footprint well and a buyer will see a tight, efficient site. If you're at $140,000 per op, you have capacity a platform could fill, which is a story to tell in diligence, and also a reason to ask why you haven't filled it yourself.

Diligence Runs Three to Six Months, and That's Where Deals Change

A private-buyer sale typically closes on 30 to 60 days of due diligence; DSO diligence runs three to six months. Those months are not a formality. They're where the buyer rebuilds your financials to their own standard, and where the number you shook hands on moves.

Expect the recast to add back less than you think and normalize more than you'd like: your spouse's payroll, the vehicle, the CE trips, the above-market rent you pay your own building LLC, the associate you're underpaying relative to market. Every one of those adjustments comes straight off EBITDA and gets multiplied by six. A $35,000 normalization at 6x takes $210,000 off the price.

The defense is to run that recast yourself, twelve months before you take a call, and fix what's fixable. Pay the associate market rate and see what's left. Set the rent at a defensible market figure. Clean the personal expenses out of the P&L. You will hate the resulting EBITDA number, and that number is the one you're actually selling.

Five Conditions That Make Us Say Sell

• Adjusted EBITDA above roughly $800,000, which puts you in or near the band where multiples step up to 7x to 9x rather than 5x to 7x.
• Two or more locations with shared overhead, because that's the structure platforms pay up for.
• You want out of clinical dentistry within five years anyway, so the employment commitment costs you nothing you weren't going to give up.
• Your local buyer pool is genuinely thin, meaning no credible associate, no partner, no incoming graduate who can get financing in your market.
• You have a specific, dated plan for the cash. Deals look much worse when the proceeds sit in a money market while you keep drilling.

Four Conditions That Should Stop You Cold

• You're under about $300,000 of adjusted EBITDA with one location. The multiple band is at its lowest exactly where your forgone earnings are proportionally largest.
• More than a quarter of consideration is rollover equity and you can't afford for it to be worth zero.
• You're ten-plus years from any retirement date. A four-year commitment and a non-compete, followed by six years as somebody's employee, is a long way to go for a pulled-forward paycheck.
• You're selling because you're exhausted and you haven't tried the $90,000 management hire first.

A DSO deal doesn't buy your practice so much as it buys your next four years, and hands you a receipt for them. Whether that's a good trade depends entirely on what those four years were going to be worth to you anyway.

Do These Four Things Before You Take the Next Call

This week, pull your last twelve months of P&L and rebuild it with yourself paid at 30% of your own production and your rent set at market. That's your real adjusted EBITDA, and multiplying it by 5, 6 and 7 gives you the only price range worth discussing. Then write down, in dollars, what you'd earn over the next four years if you did nothing at all, and put the two numbers side by side. If the gap is under half a million, don't take the meeting yet. Go fix the practice.

If you want a second read on where your EBITDA and value range actually land before a buyer's analyst tells you, run your own numbers through our free practice valuation calculator. It walks the same normalizations a DSO's diligence team will run on you, including owner compensation and rent, so the first time you see the recast number it's on your own screen instead of in a revised letter of intent.

What we're watching next: whether multiples at the small end hold as platform recapitalizations slow, and whether any meaningful share of sub-$1.5 million sellers actually see their rollover equity pay out at second-bite prices. If that payout record turns out to be solid rather than anecdotal, the arithmetic above changes, and we'd revise the call for owners in the $200,000 to $400,000 EBITDA range. We haven't seen the evidence yet.